Subarachnoid hemorrhage in the African-American population: A cooperative study

Journal of the National Medical Association

Volumn 89, Issue 2, 1997, Pages 101-108

  Dennis, Gary C ^a   Welch, Babu ^b   Cole, Arthur N ^b   Mendoza, Raphael ^b   Morgan, Jay ^b   Epps, Joseph ^b   Bernard, Estrada ^b   St Louis, Phillip ^b  

^a HOWARD UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

African Americans; Cerebral ischemia; Hypertension; Subarachnoid hemorrhage

Indexed keywords

AMINOCAPROIC ACID DERIVATIVE; ANTIFIBRINOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; COHORT ANALYSIS; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; NEGRO; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; AMINOCAPROIC ACIDS; ANTIFIBRINOLYTIC AGENTS; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIMODIPINE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0031065293     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kassel NF, Tomer JC. The International Cooperative Study on Timing of Aneurysm Surgery - an update. Stroke. 1984;15:566-570.
2. Sahs A, Perret GE, Locksley HB, Nishioka H. Intracranial Aneurysms and Subarachnoid Hemorrhage. Philadelphia, Pa: JB Lippincott Co; 1969.
3. McCormick WF, Rosenfield DB. Massive brain hemorrhage; a review of 144 cases and an examination of their causes. Stroke. 1973;4:946-954.
4. Kassel NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11:337-343.
5. Adams HP, Kassel NF, Torner JC, Haley EC. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influence of clinical condition, CT results and antifibrinolytic therapy. A Report of the Cooperative Study. Neurology. 1987;36:1586.
6. Hijdra A, van Gijn J, Nagelkerke NJD, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19:1250-1256.
7. Graham DL, MacPherson P, Pitts LH. Correlation between angiographic vasospasm, hematoma, and ischemic brain damage following subarachnoid hemorrhage. J Neurosurg. 1983;59:223-230.
8. Ohman J, Servo A, Heiskanen O. Risk factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg. 1991;74:14-20.
9. Wilkins RH, Rengachary SS. Neurosurgery. New York, NY: McGraw-Hill; 1985.
10. Artiola I, Fortuny L, Adams CBT, Briggs M. Surgical mortality in an aneurysm population: effects of age, blood pressure and preoperative neurological state. J Neurol Neurosurg Psychiatry. 1980;43:879-882.
11. Disney L, Weir BKA, Grace M, Canadian Nimodipine Study. Factors influencing the outcome of aneurysm rupture in poor grade patients: a prospective series. Neurosurgery. 1988;23:1-9.
12. Ohman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg. 1991;74:8-11.
13. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, et al. Cerebral arterial spasm. A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619-624.
14. Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, et al. Nimodipine treatment in poor-grade aneurysm patients. J Neurosurg. 1988;68:505-517.
15. Pickard JF, Murray GD, Illingworth R, Shaw MDM, Teasedale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J. 1989;298:636-642.
16. Haley EC Jr, Kassell NF, Tomer JC. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. J Neurosurg. 1993;78:548-553.
17. Mercier P, Alhayek G, Rizk T, Fournier D, Menei P, Guy G. Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery. 1994;34:30-37.
18. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14-20.
19. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81-84.
20. White R. Responses of isolated cerebral arteries to vasoactive agents. Neurosurg Clin N Am. 1990;1:401-415.
21. Chyatte D, Sundt T. Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc. 1984;59:498-505.
22. Liszczak TM, Varso VG, Black PMcL, Kistler JP, Zervas NT Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg. 1983;58:18-26.
23. White R, Hagen AA. Cerebrovascular actions of prostaglandins. Pharmacol Ther. 1982;18:313-331.
24. Weir BK, Okwuasaba FK, Cook DA, Krueger CA. Pharmacology of vasospasm-effects of various agents including blood of isolated cerebral arteries. In: Wilkins RH, ed. Cerebral Arterial Spasm. Baltimore, Md: Williams & Wilkins; 1980:237-243.
25. Fraser RA, Stein BM, Barret RE. Noradrenergic mediation of experimental cerebrovascular spasm. Stroke. 1970;1:356-362.
26. Dennis GC, Cole AN. Cerebral aneurysms in African Americans. Presented at the Annual Convention and Scientific Assembly of the National Medical Association; July 15-20, 1989; Orlando, Florida.
27. Longstreth JR, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 1992;23:1242-1249.
28. Fischer CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;5:1-9.
29. Gurusinghe NT, Richardson AE. The value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture. J Neurosurg. 1980;60:763-770.
30. Mizukami M, Takemae T, Tazawa T, Kawase T, Matsuzaki T. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture. Neruosurgery. 1980;7:583-586.
31. Sander D, Klingelhofer J. Cerebral vasospasm following post-traumatic subarachnoid hemorrhage evaluated by transcranial Doppler ultrasonography. J Neurol Sci. 1993;119:1-7.
32. Steiger H-J, Aaslid R, Stooss R, Seiler RW. Transcranial Doppler monitoring in head injury: relations between type of injury, flow velocities, vasoreactivity, and outcome. Neurosurgery. 1994;34:79-85.
33. Friday G, Lai SM, Alter M, Sobel E, LaRue L, Gil-Peralta A, et al. Stroke in the Lehigh Valley: racial/ethnic differences. Neurology. 1989;39:1165-1168.
34. Beevers DG, Fairman MJ, Hamilton M, Harpur JE. Antihypertensive treatment and the course of established cerebral vascular disease. Lancet. 1973;1:1407-1409.
35. Siegel PZ, Deeb LC, Wolfe LE, Wilcox D, Marks JS. Stroke mortality and its socioeconomic, racial, and behavioral correlates in Florida. Public Health Rep. 1993;108:454-458.
36. Homer D, Whisnant JP, Schoenberg BS. Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935. Ann Neurol. 1987;22:245-251.
37. Meissner I, Whisnant JP. Hypertension management and stroke recurrence in a community (Rochester, MN 1950-1979). In: Proceedings of the 12th International Joint Conference on Stroke and Cerebral Circulation. 1987:23.
38. The European Study Group on Nimodipine in Severe Head Injury. A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. J Neurosurg. 1994;80:797-804.
39. Miller JD, Smith RR. Transcranial Doppler sonography in aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev. 1994;6:31-46.
40. Mizuno M, Nakajima S, Sampei T, Nishimura H, Hadeishi H, Suzuki A, et al. Serial transcranial Doppler flow velocity and cerebral blood flow measurements for evaluation of cerebral vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 1994;34:164-171.
41. Schregel W. Value of transcranial Doppler sonography. Infusionsther Transfusionsmed. 1993;20:267-271.
42. Ross JS, Masaryk TJ, Modic MT, Ruggieri PM, Haacke EM, Selman WR. Intracranial aneurysms: evaluation by MR angiography. AJR Am J Roentgenol. 1990;155:159-165.
43. Schuierer G, Nuk WJ, Laub G. Magnetic resonance angiography of intracranial aneurysms: comparison with intra-arterial digital subtraction angiography. Neuroradiology. 1992;35:50-55.
44. Gouliamos A, Gotsis E, Vlahos L, Samara C, Kapsalaki E, Rologis D, et al. Magnetic resonance angiography compared to intra-arterial digital subtraction angiography in patients with subarachnoid hemorrhage. Neuroradiology. 1992;35:46-49.
45. Hall ED. Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders. Ann Neurol. 32(suppl):S137-142.
46. Matsui T, Asano T. Effects of new 21-ammosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a 'two hemorrhage model of beagle dogs.' Neurosurgery. 1994;34:1035-1039.
47. Shishido T, Suzuki R, Quian L, Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke. 1994;24:864-868.
48. Choi M, Ehrlich HP. U75412E, a lazaroid, prevents progressive burn ischemia in a rat burn model. Am J Pathol. 1993;142:519-528.
49. Grimes CM. Cerebral balloon angioplasty for the treatment of vasospasm after subarachnoid hemorrhage. Heart Lung. 1991;20:431-435.
50. Higashida RT, Halbach VV, Cahan LD, Brant-Zawadski M Barnwell S, Dowd C, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg. 1989;71:648-653.
51. Zubkov YN, Alexander LF, Smith RR, Benashvilli GM, Semenyutin V, Bernanke D. Angioplasty of vasospasm: is it reasonable? Neural Res. 1994;16:9-11.
52. LeRoux PD, Newell DW, Eskridge J, Mayberg MR, Winn HR. Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg. 1994;80:224-229.
53. Linskey ME, Horton JA, Rao GR, Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg. 1991;74:985-990.
54. Bevan JA, Bevan RD, Frazec JG. Functional arterial changes in chronic cerebrovasospasm in monkeys; an in vitro assessment of the contribution to arterial narrowing. Stroke. 1987;18:472-481.
55. Fleishaker JC, Hulst JK, Peters GR. Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/dav administered over 5-10 days in health volunteers. Int J Clin Pharmocol Ther. 1994;32:223-230.